CHARLESTON, S.C., Jan. 7, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation (‘Revolutions Medical” or the “Company”) (OTCBB:RMCP), in response to a substantial increase in demand for its 1ml safety syringe from the global marketplace, has secured a 5-year contract to produce 5 million syringes per month of its RevVac 1ml fixed needle safety syringe. The production capacity can be increased to 20 million syringes per month, and shipments will begin by July 2011.
